Pharming Group NV (PHARM) — Long-term Investment Intensity
Pharming Group NV (PHARM) has a Long-term Investment Intensity of 1.4% as of September 2025. Long-term investments of €6.67 Million represent 1.4% of total assets of €473.79 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of Pharming Group NV to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Pharming Group NV Long-term Investment Intensity (2019–2024)
This chart shows how Pharming Group NV's Long-term Investment Intensity has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the intensity stands at 1.4%, reflecting long-term investments of €6.67 Million against total assets of €473.79 Million EUR. For the complete balance sheet picture, see Pharming Group NV asset portfolio.
Annual Long-term Investment Intensity for Pharming Group NV (2019–2024)
The table below presents the year-by-year Long-term Investment Intensity for Pharming Group NV from 2019 to 2024, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Pharming Group NV debt and liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 1.1% | €4.23 Million | €386.88 Million | ▼ -1.3 pp |
| 2023 | 2.4% | €10.40 Million | €426.34 Million | ▲ +0.2 pp |
| 2022 | 2.3% | €9.73 Million | €425.80 Million | ▲ +0.1 pp |
| 2021 | 2.2% | €8.79 Million | €396.90 Million | ▲ +0.8 pp |
| 2020 | 1.4% | €5.80 Million | €419.12 Million | ▼ -0.7 pp |
| 2019 | 2.1% | €5.31 Million | €255.63 Million | — |